Old Web
English
Sign In
Acemap
>
authorDetail
>
Nagaaki Sato
Nagaaki Sato
Taisho Pharmaceutical Co.
Biochemistry
Chemistry
Tetrahydroisoquinoline
Enzyme
Potency
3
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification of 2-[2-(4-tert-Butylphenyl)ethyl]-N-[4-(3-cyclopentylpropyl)-2-fluorophenyl]-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide as an Orally Active MGAT2 Inhibitor
2016
Chemical & Pharmaceutical Bulletin
Tsuyoshi Busujima
Hiroaki Tanaka
Kanako Iwakiri
Yoshihisa Shirasaki
Eiji Munetomo
Masako Saito
Aiko Masuko
Kiyokazu Kitano
Fusayo Io
Koji Kato
Shunsuke Kamigaso
Akiko Nozoe
Nagaaki Sato
Show All
Source
Cite
Save
Citations (2)
Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.
2015
Bioorganic & Medicinal Chemistry
Tsuyoshi Busujima
Hiroaki Tanaka
Yoshihisa Shirasaki
Eiji Munetomo
Masako Saito
Kiyokazu Kitano
Toshiya Minagawa
Koji Yoshida
Naoto Osaki
Nagaaki Sato
Show All
Source
Cite
Save
Citations (5)
Modulation of neuropeptide Y receptors for the treatment of obesity
2009
Expert Opinion on Therapeutic Patents
Nagaaki Sato
Yoshio Ogino
Satoshi Mashiko
Makoto Ando
Show All
Source
Cite
Save
Citations (52)
1